Form 4 holding
Director
Crinetics Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 116,146
- Estimated value
- $3,869,984
- Report date
- 11 Jun 2025
- Price
- $33.32
- Ownership
- Direct
Wendall Wierenga - Director at Crinetics Pharmaceuticals, Inc.
Insider Transactions and Holdings
- Entity type
- Individual
- Role
- Director
- Issuer symbol
- CRNX on Nasdaq
- Source filings
- Open source filing history
Identity
Issuer context
SEC evidence
There are no Buy or Sell transactions made by Wendall Wierenga since 01 Jun 2025
Holdings reported by Wendall Wierenga for Crinetics Pharmaceuticals, Inc.
Form 4 holding
Director
Crinetics Pharmaceuticals, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 10,350
- Estimated value
- Report date
- 11 Jun 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Wendall Wierenga for Crinetics Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
* indicates a reported price that failed the local validity check.